AsoGen Therapeutics IVS

CVR number: 40357092
Sivlandvænget 3, Hjallese 5260 Odense S
ska@dcm.aau.dk
tel: 27796814

Income statement (kDKK)

20192020
Fiscal period length1212
Net sales
External services-5.00-7.01
Gross profit-5.00-7.01
Total depreciation-11.08
EBIT-5.00-18.09
Other financial expenses-11.64-21.21
Pre-tax profit-16.64-39.30
Net earnings-16.64-39.30

Assets (kDKK)

20192020
Intangible rights98.55209.87
Intangible assets total98.55209.87
Tangible assets total
Investments total
Long term receivables total
Inventories total
Current other receivables24.847.21
Short term receivables total24.847.21
Cash and bank deposits141.1321.31
Cash and cash equivalents141.1321.31
Balance sheet total (assets)264.51238.39

Equity and liabilities (kDKK)

20192020
Share capital0.200.20
Retained earnings-16.64
Profit of the financial year-16.64-39.30
Shareholders equity total-16.44-55.74
Non-current owed to group member260.96271.64
Non-current liabilities total260.96271.64
Current trade creditors20.0022.50
Current liabilities total20.0022.50
Balance sheet total (liabilities)264.51238.39
Try the full version of our system for free
Bankruptcy risk visualization example

... and more!

No registration needed.